Our Work
Latham & Watkins Advises GT MedTech in US$37 Million Series D Financing
January 16, 2025
Emerging Companies & Growth team represented the medical device company in the funding round.
GT Medical Technologies, Inc. (GT MedTech), a medical device company with a corporate purpose of improving the lives of patients with brain tumors, has announced the company has completed a US$37 million first close of a Series D financing round.
Latham & Watkins LLP represented GT MedTech in the transaction with an Emerging Companies & Growth team led by Bay Area partners Luke Bergstrom and Benjamin Potter, with associates Omar Ammash, Erica Kucharski, and Amarantha Gomez.